Comparison of Vasodilator Response of Inhaled Epoprostenol and Inhaled Nitric Oxide
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 115 participants.
Also called NCT04231084
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose diagnostic
- Phase
- Phase 4
- Enrolled
- 115 participants
- Sponsor
- Registry
-
NCT04231084
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT04231084. Randomized; triple masking; primary purpose diagnostic. Start 2021-01-15 (actual); primary completion 2024-08-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Vasodilator Response of Inhaled Epoprostenol and Inhaled Nitric Oxide
- Condition
- Pulmonary Hypertension
- Intervention (Drug)
- Vasodilator testing (Inhaled Nitric Oxide)
- Intervention (Drug)
- Vasodilator testing (Inhaled Epoprostenol)
- Lead sponsor
- Brigham and Women's Hospital
Record details
- Record id
cardio:ct-nct04231084- Content hash
7946545d6e1da6f65f42fd773a8f0f10aa9a8a7af2778f46aa9f20eb6fb4d1f2